Pharmaceutical composition for preventing or treating intestinal damage comprising Leuconostoc citreum strain as active ingredient
AssigneeLiscure Biosciences Co., Ltd.
InventorHwa Sup Chin
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising a Leuconostoc citreum strain or a culture thereof as an active ingredient for preventing, improving or treating intestinal damage, specifically intestinal damage caused by inflammatory bowel disease, non-alcoholic steatohepatitis or chemotherapy. According to the present invention, since the composition exhibits excellent preventive and therapeutic effects on various intestinal damages such as inflammatory bowel disease, non-alcoholic steatohepatitis, and chemotherapy, the composition can be usefully used as a composition for the treatment, prevention or improvement of human or animal intestinal damage.
Claims3
A method for treating intestinal damage related to dysfunction of tight junction, the method comprising administering a composition comprising a Leuconostoc citreum WiKim0104 strain having accession number KCCM12420P and having the nucleic acid sequence of SEQ ID NO:
- 1 or a culture comprising the Leuconostoc citreum WiKim0104 strain as an active ingredient to a subject in need thereof, wherein the intestinal damage is caused by inflammatory bowel disease or chemotherapy.
Dependencies are inferred from the claim text.